UBS Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-472
| Closed | -$6K | – | 7889 |
|
|
2020
Q3 | $6K | Buy |
+472
| New | +$6K | ﹤0.01% | 6383 |
|
|
2020
Q2 | – | Sell |
-145
| Closed | -$1K | – | 7510 |
|
|
2020
Q1 | $1K | Sell |
145
-186
| -56% | -$1.28K | ﹤0.01% | 6945 |
|
|
2019
Q4 | $5K | Sell |
331
-1,245
| -79% | -$18.8K | ﹤0.01% | 6539 |
|
|
2019
Q3 | $26K | Sell |
1,576
-902
| -36% | -$14.9K | ﹤0.01% | 5632 |
|
|
2019
Q2 | $34K | Buy |
+2,478
| New | +$34K | ﹤0.01% | 5377 |
|
|
2019
Q1 | – | Sell |
-10,557
| Closed | -$135K | – | 7289 |
|
|
2018
Q4 | $135K | Buy |
10,557
+4,342
| +70% | +$55.5K | ﹤0.01% | 4420 |
|
|
2018
Q3 | $101K | Buy |
6,215
+2,785
| +81% | +$45.3K | ﹤0.01% | 4730 |
|
|
2018
Q2 | $44K | Buy |
3,430
+2,469
| +257% | +$31.7K | ﹤0.01% | 5186 |
|
|
2018
Q1 | $12K | Sell |
961
-284
| -23% | -$3.55K | ﹤0.01% | 5896 |
|
|
2017
Q4 | $17K | Sell |
1,245
-478
| -28% | -$6.53K | ﹤0.01% | 5725 |
|
|
2017
Q3 | $29K | Buy |
1,723
+1,573
| +1,049% | +$26.5K | ﹤0.01% | 5296 |
|
|
2017
Q2 | $3K | Sell |
150
-1,697
| -92% | -$33.9K | ﹤0.01% | 6368 |
|
|
2017
Q1 | $29K | Sell |
1,847
-2,331
| -56% | -$36.6K | ﹤0.01% | 4985 |
|
|
2016
Q4 | $62K | Buy |
4,178
+3,284
| +367% | +$48.7K | ﹤0.01% | 4757 |
|
|
2016
Q3 | $11K | Buy |
+894
| New | +$11K | ﹤0.01% | 5826 |
|
|
2016
Q1 | – | Sell |
-2,520
| Closed | -$29K | – | 6985 |
|
|
2015
Q4 | $29K | Buy |
2,520
+1,730
| +219% | +$19.9K | ﹤0.01% | 5241 |
|
|
2015
Q3 | $11K | Sell |
790
-126
| -14% | -$1.75K | ﹤0.01% | 5878 |
|
|
2015
Q2 | $13K | Buy |
+916
| New | +$13K | ﹤0.01% | 5827 |
|
|
2015
Q1 | – | Sell |
-556
| Closed | -$8K | – | 6885 |
|
|
2014
Q4 | $8K | Buy |
+556
| New | +$8K | ﹤0.01% | 6145 |
|